At a glance
- Originator Fujisawa
- Class Small molecules
- Mechanism of Action Platelet activating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Disseminated intravascular coagulation
Most Recent Events
- 23 Jun 1998 Commercial data has been reviewed by Fujisawa
- 05 Nov 1997 No-Development-Reported for Asthma in Japan (Unknown route)
- 05 Nov 1997 No-Development-Reported for Disseminated intravascular coagulation in Japan (Unknown route)